639 related articles for article (PubMed ID: 17851077)
41. Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy--a feasibility and toxicity study.
Teh AY; Walsh L; Purdie TG; Mosseri A; Xu W; Levin W; Koch CA; Fyles A; Liu FF; Cho BC
Radiother Oncol; 2012 Jan; 102(1):89-95. PubMed ID: 22112781
[TBL] [Abstract][Full Text] [Related]
42. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
Kirova YM; Campana F; Savignoni A; Laki F; Muresan M; Dendale R; Bollet MA; Salmon RJ; Fourquet A;
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):76-81. PubMed ID: 19168297
[TBL] [Abstract][Full Text] [Related]
43. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes.
Fujii O; Hiratsuka J; Nagase N; Tokiya R; Yoden E; Sonoo H; Murashima N; Iha S; Imajyo Y
Breast Cancer; 2008; 15(1):86-92. PubMed ID: 18224401
[TBL] [Abstract][Full Text] [Related]
44. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
45. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.
Chadha M; Vongtama D; Friedmann P; Parris C; Boolbol SK; Woode R; Harrison LB
Clin Breast Cancer; 2012 Feb; 12(1):57-62. PubMed ID: 22056970
[TBL] [Abstract][Full Text] [Related]
46. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
47. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
[TBL] [Abstract][Full Text] [Related]
48. Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer.
Martin S; Mannino M; Rostom A; Tait D; Donovan E; Eagle S; Haviland J; Yarnold J
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):502-5. PubMed ID: 18556186
[TBL] [Abstract][Full Text] [Related]
49. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy timing in 4,820 patients with breast cancer: university of florence experience.
Livi L; Borghesi S; Saieva C; Meattini I; Rampini A; Petrucci A; Detti B; Bruni A; Paiar F; Mangoni M; Marrazzo L; Agresti B; Cataliotti L; Bianchi S; Biti G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):365-9. PubMed ID: 18715726
[TBL] [Abstract][Full Text] [Related]
51. Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy; out come of 7 months follow-up.
Raiyawa T; Lertbutsayanukul C; Rojpornpradit P
J Med Assoc Thai; 2009 Mar; 92(3):390-7. PubMed ID: 19301734
[TBL] [Abstract][Full Text] [Related]
52. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
[TBL] [Abstract][Full Text] [Related]
53. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
Buchholz TA; Strom EA; Oswald MJ; Perkins GH; Oh J; Domain D; Yu TK; Woodward WA; Tereffe W; Singletary SE; Thomas E; Buzdar AU; Hortobagyi GN; McNeese MD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1155-60. PubMed ID: 16750325
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university.
Corvò R; Ricchetti F; Doino D; Torielli P; Agostinelli S; Cavagnetto F; Giannelli F; D'Alonzo A; Vagge S; Belgioia L; Guenzi M
Anticancer Res; 2010 Nov; 30(11):4749-53. PubMed ID: 21115935
[TBL] [Abstract][Full Text] [Related]
55. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
[TBL] [Abstract][Full Text] [Related]
56. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
57. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
[TBL] [Abstract][Full Text] [Related]
58. [The effect of tumour bed boost on local control after breast conserving surgery. First results of the randomized boost trial of the National Institute of Oncology].
Polgár C; Fodor J; Orosz Z; Major T; Mangel L; Takácsi-Nagy Z; Sulyok Z; Somogyi A; Tóth J; Köves I; Kásler M; Németh G
Magy Onkol; 2001; 45(5):385-391. PubMed ID: 12050684
[TBL] [Abstract][Full Text] [Related]
59. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
60. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
